Phio Pharmaceuticals director David H. Deming reports acquisition of $10,066.20 in common shares

PHIO•2026-11-12

Director David H. Deming purchased 12,000 Phio Pharmaceuticals common shares for $10,066.20, bringing his direct beneficial ownership to 49,800 shares.

1. Share purchases

Deming bought 6,800 shares at $0.8395 each and 5,200 shares at $0.838 each, for a total purchase of $10,066.20.

Sources

Phio Pharmaceuticals director David H. Deming reports acquisition of $10,066.20 in common shares

Sec

Phio Pharmaceuticals director David H. Deming reports acquisition of $10,066.20 in common shares

1. Share purchases

Related News

PayPal partners with Workday to enhance employee financial well-being with PayPal direct deposit

MeiraGTx Holdings files for mixed shelf; size not disclosed

Nasdaq trade halt: volatility trading pause at 9:54 a.m.

Sources

Phio Pharmaceuticals director David H. Deming reports acquisition of $10,066.20 in common shares

Sound Point Meridian Capital estimates NAV per share at $8.41 to $8.51 as of Oct. 31

Speaker Johnson says Congress developing consensus on limiting chip exports to China